5 Biotech Stocks With The Biggest Upside

In this article, we discuss the 5 biotech stocks with the biggest upside. If you want to read about some more biotech stocks with the biggest upside, go directly to 10 Biotech Stocks With The Biggest Upside.

5. Veru Inc. (NASDAQ:VERU)

Number of Hedge Fund Holders: 13      

Veru Inc. (NASDAQ:VERU) is a biopharmaceutical company that focuses on developing medicines for the management of COVID-19, and breast and prostate cancers. On November 9, Veru Inc declared the results of its meeting with the US Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee, which reviewed sabizabulin for Emergency Use Authorization in hospitalized moderate to severe COVID-19 patients who are at high risk for acute respiratory distress syndrome.

On November 10, H.C. Wainwright analyst Yi Chen maintained a Buy rating on Veru Inc. (NASDAQ:VERU) stock and lowered the price target on Veru to $21 from $24, noting that FDA might deny the company’s EUA application and requested additional clinical data.

Among the hedge funds being tracked by Insider Monkey, Chicago-based investment firm Perceptive Advisors is a leading shareholder in Veru Inc. (NASDAQ:VERU) with 3.9 million shares worth more than $44.8 million.